The only data concerning the incidence of haematopoietic malignancies prior to 1975 in France came from death certificates. However, these certificates are often imprecise or incomplete. Therefore, French mortality data were not included in the last volume of Cancer Incidence in Five Continents . Since 1975, four registries have been established in France (Schraub, 1983) . A population based registry specializing in haematopoietic malignancies was created in the department of Cote d'Or in 1980. As population based registries in France are recent, incidence data about haematopoietic malignancies in this country are not yet well known; the purpose of this study is to report the incidence and the characteristics of haematopoietic malignancies in the department of Cote d'Or.
Materials and methods
The study included all patients residing in the department of Cote d'Or in whom a haematopoietic malignancy was diagnosed for the first time between January 1, 1980 and December 31, 1984 . The population of C6te d'Or consisted of 234,900 males and 243,100 females (Schmitt, 1981 indexes (by name, by date of birth and by nature of haemopathy) to eliminate duplication.
This registration took place under excellent conditions; biological information exists for all cases, clinical information in 98% of the cases, and there was an average of three notifications per case. The morbidity/mortality ratio was 1.9.
The registration included all haematopoietic malignancies and dysmyelopoietic syndromes: acute leukaemias, lymphoid and myeloid proliferative disorders, Hodgkin's and non Hodgkin's lymphomas. Acute leukaemias and dysmyelopoietic syndromes were classified according to the FAB co-operative group (Bennet et al., 1976) . The 8th International Classification of Diseases was also adopted (World Health Organization, 1967) to permit comparison with other countries (Schmitt, 1981) . For the purpose of regional comparison, rates have been standardized by the direct method using the world standard population (Segi & Kurihara, 1969 For the most frequent haemopathies, age and sex specific incidence rates are given in Figure 1 . In acute leukaemias, incidence rates in males and females were comparable. In chronic lymphocytic leukaemias, incidence rates were low before 50 years of age and rose in the older age groups, with a male predominance. In Hodgkin's lymphoma there were no cases before 5 years of age, and incidence was higher between 20 and 55 years old. In non Hodgkin's lymphoma, the incidence increased in all age groups over 55 years.
The mean ages of the patients at time of diagnosis by type of haematopoietic malignancy are given in Table II . There were no significant differences except for chronic lymphocytic leukaemias: females patients were older than males (P<0.05).
Urban-rural differences There were no significant variations in incidence for the different types of haematopoietic malignancy, but there was a trend towards a higher incidence in urban than in rural areas for all types except acute leukaemias in females. When rates were added, the risk of haematopoietic malignancies was significantly higher in urban than in rural areas. In males, the age standardized rates were respectively 30.9/100,000 and 20.4/100,000 (P<0.01). In females, they were 18.7/100,000 and 13.9/100,000 (P <0.05). In this paper, in order to compare our results with those of other registries , it was necessary to use the 8th revision (World Health Organization, 1967) . Available classification of haematopoietic malignancies involved difficulties: in the 7th revision, it was not even possible to separate acute and chronic leukaemias. In the 8th revision, myelodysplastic syndromes were not included (except chronic monocytic leukaemias). In the 9th revision, they were included but in ICD codes far from those of haematopoietic malignancies . In the 10th revision, it would be unfortunate not to use the FAB classification concerning acute leukaemias and dys- myelopoietic syndromes, seeing that classification is actually used by most of the haematologists. One of the most important uses of registered data is to permit comparison with the data of cancer registries in other countries (Table III) . For the whole range of haematopoietic malignancies, high rates are reported in the department of Cote d'Or as well as in most West European and North American countries. Incidence rates are in the intermediate range in Norway and South Africa and they are low in Asia (particularly in Japan). They are higher in Cote d'Or than in other populationbased French registries. It must be underlined that an unexpected high incidence rate for chronic lymphocytic leukaemias was found. There are two possible explanations for such a special situation. One is that the incidence of chronic lymphocytic leukaemia in Cote d'Or does not differ from that in other places, except that the reporting of the cases is more complete in Cote d'Or. The other is that chronic lymphocytic leukaemia is really more frequent in our department. Case-control studies are necessary to search for environmental and occupational factors. The results could explain this high incidence rate. For multiple myeloma, the rates are in the intermediate range, lower than in countries with a high black population. Hodgkin's and non-Hodgkin's lymphomas are frequent but less than in Geneva (Switzerland), a very high risk region. For the other haematopoietic malignancies. Cote d'Or rates are similar to those reported in most countries. As in most cancer registries, the male/female ratio of incidence rates was about 1:1 for acute leukaemias (as for everywhere in the world), while there was a high male predominance for chronic leukaemias.
Comparison of urban and rural incidence data are difficult because the definitions of urban and rural vary a great deal from one area of the world to another. The definition of urban and rural used in France is based on the size of the population; urban areas include agglomerations of more than 2,000 inhabitants. Although comparisons need to be treated with caution, they show a similar trend; there was a tendency towards a slightly higher urban rate for most of the types of haematopoietic malignancies (significantly higher for whole haemopathies). In Iowa, an increasing incidence of chronic lymphocytic leukaemias from urban to rural areas was noted (Donham et al., 1980) . This fact suggests the possibility of an environmental exposure. The purpose of population-based registries is to search for aetiologic factors. They are not yet known except for therapeutic drugs and radiation.
There are no comparable population-based statistics concerning classification of acute leukaemias and myelodysplastic syndromes according to FAB classification. In acute lymphoid leukaemias, the LI was the predominant type, and in acute myeloid leukaemias the M2 type was more frequent than Ml, M4 and M5 types. For dysmyelopoietic syndromes, the refractory anaemias with excess of blasts represent about half of the cases. Comparison with data from Iowa (Dick et al., 1982) shows similar results except for LI and L2 classes. However, Cote d'Or data include children, and those of Dick et al. only adults. These data are interesting as they concern an overall population. They provide clinicians with data for reference and public health authorities with a basis for monitoring cancer patients. 
